Huh, Malcolm Gladwell has a new book out: David and Goliath: Underdogs, Misfits, and the Art of Battling Giants. Here’s the synopsis:
Three thousand years ago on a battlefield in ancient Palestine, a shepherd boy felled a mighty warrior with nothing more than a stone and a sling, and ever since then the names of David and Goliath have stood for battles between underdogs and giants. David’s victory was improbable and miraculous. He shouldn’t have won.
Or should he have?
In David and Goliath, Malcolm Gladwell challenges how we think about obstacles and disadvantages, offering a new interpretation of what it means to be discriminated against, or cope with a disability, or lose a parent, or attend a mediocre school, or suffer from any number of other apparent setbacks.
Tyler Cowen liked it:
Take the book’s central message to be “here’s how to think more deeply about what you are seeing.” To be sure, this is not a book for econometricians, but it so unambiguously improves the quality of the usual public debates, in addition to entertaining and inspiring and informing us, I am very happy to recommend it to anyone who might be tempted.
Christopher Chabris at the Wall Street Journal was not so kind:
One thing “David and Goliath” shows is that Mr. Gladwell has not changed his own strategy, despite serious criticism of his prior work. What he presents are mostly just intriguing possibilities and musings about human behavior, but what his publisher sells them as, and what his readers may incorrectly take them for, are lawful, causal rules that explain how the world really works. Mr. Gladwell should acknowledge when he is speculating or working with thin evidentiary soup. Yet far from abandoning his hand or even standing pat, Mr. Gladwell has doubled down. This will surely bring more success to a Goliath of nonfiction writing, but not to his readers.
I enjoy Gladwell’s writing and am able to take it with the proper portion of salt…I read (and write about) most pop science as science fiction: good for thinking about things in novel ways but not so great for basing your cancer treatment on. I skipped Outliers but maybe I should give this one a try?